Close Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.07M | Buy |
4,923
+157
| +3% | +$34.8K | 0.03% | 79 |
|
|
2025
Q4 | $1.09M | Sell |
4,766
-60
| -1% | -$13.7K | 0.02% | 81 |
|
|
2025
Q3 | $1.12M | Sell |
4,826
-177
| -4% | -$36K | 0.02% | 82 |
|
|
2025
Q2 | $928K | Hold |
5,003
| – | – | 0.03% | 81 |
|
|
2025
Q1 | $1.05M | Hold |
5,003
| – | – | 0.03% | 77 |
|
|
2024
Q4 | $890K | Hold |
5,003
| – | – | 0.03% | 81 |
|
|
2024
Q3 | $988K | Hold |
5,003
| – | – | 0.03% | 79 |
|
|
2024
Q2 | $857K | Buy |
5,003
+60
| +1% | +$9.94K | 0.03% | 79 |
|
|
2024
Q1 | $899K | Hold |
4,943
| – | – | 0.03% | 76 |
|
|
2023
Q4 | $766K | Sell |
4,943
-225
| -4% | -$32.8K | 0.03% | 73 |
|
|
2023
Q3 | $771K | Buy |
5,168
+25
| +0.5% | +$3.67K | 0.04% | 74 |
|
|
2023
Q2 | $693K | Buy |
5,143
+223
| +5% | +$32.7K | 0.03% | 75 |
|
|
2023
Q1 | $784K | Sell |
4,920
-230
| -4% | -$35.2K | 0.04% | 70 |
|
|
2022
Q4 | $832K | Hold |
5,150
| – | – | 0.04% | 64 |
|
|
2022
Q3 | $692K | Hold |
5,150
| – | – | 0.04% | 65 |
|
|
2022
Q2 | $790K | Sell |
5,150
-50
| -1% | -$7.64K | 0.04% | 67 |
|
|
2022
Q1 | $704K | Hold |
5,200
| – | – | 0.03% | 63 |
|
|
2021
Q4 | $704K | Sell |
5,200
-150
| -3% | -$17.7K | 0.03% | 63 |
|
|
2021
Q3 | $577K | Hold |
5,350
| – | – | 0.03% | 67 |
|
|
2021
Q2 | $602K | Hold |
5,350
| – | – | 0.03% | 72 |
|
|
2021
Q1 | $579K | Hold |
5,350
| – | – | 0.03% | 76 |
|
|
2020
Q4 | $573K | Hold |
5,350
| – | – | 0.04% | 61 |
|
|
2020
Q3 | $468K | Hold |
5,350
| – | – | 0.03% | 64 |
|
|
2020
Q2 | $525K | Hold |
5,350
| – | – | 0.04% | 62 |
|
|
2020
Q1 | $407K | Hold |
5,350
| – | – | 0.04% | 65 |
|
|
2019
Q4 | $474K | Hold |
5,350
| – | – | 0.04% | 65 |
|
|
2019
Q3 | $405K | Hold |
5,350
| – | – | 0.04% | 72 |
|
|
2019
Q2 | $389K | Buy |
5,350
+150
| +3% | +$11.8K | 0.03% | 73 |
|
|
2019
Q1 | $419K | Buy |
5,200
+1,619
| +45% | +$132K | 0.04% | 70 |
|
|
2018
Q4 | $267K | Sell |
3,581
-2,119
| -37% | -$186K | 0.03% | 78 |
|
|
2018
Q3 | $539K | Buy |
5,700
+4,300
| +307% | +$408K | 0.04% | 75 |
|
|
2018
Q2 | $128K | Hold |
1,400
| – | – | 0.01% | 101 |
|
|
2018
Q1 | $128K | Hold |
1,400
| – | – | 0.01% | 104 |
|
|
2017
Q4 | $136K | Sell |
1,400
-150
| -10% | -$14.1K | 0.01% | 96 |
|
|
2017
Q3 | $138K | Hold |
1,550
| – | – | 0.01% | 96 |
|
|
2017
Q2 | $112K | Hold |
1,550
| – | – | 0.01% | 99 |
|
|
2017
Q1 | $101K | Buy |
+1,550
| New | +$97.4K | 0.01% | 99 |
|
Other funds holding ABBV
VCM
VPM
Close Asset Management's ABBV Position: Q1 2026 in Review
Close Asset Management increased its AbbVie (ABBV) stake by 3.3% in Q1 2026, buying an estimated $34.8K and bringing the position to 4,923 shares worth $1.07M. The position accounts for 0.03% of the portfolio, ranked #79.
Close Asset Management first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $1.12M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Close Asset Management held 4,923 shares of AbbVie worth $1.07M as of Q1 2026.
- Close Asset Management bought 157 AbbVie shares in Q1 2026, an estimated $34.8K.
- AbbVie made up 0.03% of Close Asset Management's portfolio in Q1 2026, its #79 holding.
- Close Asset Management first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- Close Asset Management's AbbVie position peaked at $1.12M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.